Search Results 231-240 of 17151 for egfr

  1. Cancer Treatment! Clinical Trials - Mayo Clinic Research

    A phase II study to evaluate antitumor activity of oral cMET inhibitor INC280 in adult patients with EGFR wild-type, advanced non-small cell lung cancer ...

  2. A Pilot, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Pembrolizumab for First Line Treatment of Advanced or Metastatic Non-small Cell Lung Cancer - Mayo Clinic

    Histologically or cytologically confirmed, newly diagnosed unresectable stage III or metastatic (M1a) intrathoracic NSCLC without EGFR sensitizing mutation or ...

  3. A Study of MT-0169 in Participants With Relapsed or Refractory Multiple Myeloma or non-Hodgkin Lymphoma - Mayo Clinic

    - eGFR ≥ 30 mL/min/1.73 m^2, using the MDRD equation;; ANC ≥ 1000 mm^3 (≥ 1.0*10^ 9 /L); a count of ≥ 750/mm^3 (≥ 0.75*10^ 9/L) may be acceptable for ...

  4. A Study Of Oral Methadone In Cardiac Surgery - Mayo Clinic

    Chronic kidney disease with eGFR < 30mL/min. Documented cirrhosis,. Intolerance to methadone. Inpatient status immediately prior to surgery. Subsequent ...

  5. Hypopharyngeal Cancer Clinical Trials

    The purpose of this study is to demonstrate the safety and tolerability of JAB-3312 in combination with anti-PD-1 mAb or MEKi or KRASi or EGFR-TKI in patients ...

  6. Quantitative Assessment of Tumor Ablation - Mayo Clinic

    Severe renal insufficiancy as defined by eGFR ≤30 (not on dialysis); Severe reaction to contrast not amendable to premedication. Participating Mayo Clinic ...

  7. Caloric Restriction in Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

    Males and Females ages 18-45 · Diagnosis of ADPKD with rapid progression as defined by class 1C to 1D by the imaging classification of Irazabal et al · eGFR (CD- ...

  8. A Study To Learn About The Medicine Ponsegromab In Adults With Cancer Of The Pancreas Which Has Spread And Caused Significant Body Weight Loss And Fatigue - Mayo Clinic

    Renal disease requiring dialysis or eGFR <30 mL/min/1.73m2. Note: Other protocol defined Inclusion/Exclusion Criteria may apply. Eligibility last updated 11 ...

  9. Chronic Kidney Disease Clinical Trials - Mayo Clinic Research

    ... [eGFR] <30 or on dialysis). This is a multicenter randomized controlled trial with a target randomization of ~1000 patients with advanced CKD and at least ...

  10. Presentations and Publications - Translational Neuro-Oncology: Jann N. Sarkaria - Mayo Clinic Research

    Posters · Bystander effects of EGFR-targeting 40H3 antibody-drug conjugates in glioblastoma with heterogeneous EGFR expression (PDF) · 2023 AACR annual meeting, ...